China's Hydrotalcite Market is anticipated to shoot off by the end of 2022 :Top keyplayers are Bayer, Chongqing Pharscin Pharmaceutical Co., Ltd., Sichuan Jewelland Pharmaceutical Co., Ltd., Hainan Health Care Laboratories Ltd., and Guangxi Nanning Baihui

The incidences of gastrointestinal diseases are rising in China with the development of China's economy, the change of dietary habits and daily routines, and the intensification of environmental pollution. It is estimated that the number of patients with gastrointestinal diseases in China has exceeded 120 million, and is still growing, with the incidence of chronic gastritis hovering at 30%.

Request For Free Sample@ https://www.kennethresearch.com/sample-request-10060740

According to CRI's market research, the top 5 chemical drugs for gastritis and peptic ulcer in China are all proton-pump inhibitors. Among them, the gastric mucosal protective agents represented by Hydrotalcite are featured by high safety, few side effects, and quick relief, and thus saw a growing market demand. Hydrotalcite is a gastric mucosal protective agent that can quickly neutralize gastric acid, reduce the stimulation and corrosion of gastric acid on the esophageal mucosa, and significantly relieve pains. It can also accelerate the healing of ulcers. Used to treat acute and chronic gastritis, reflux esophagitis, peptic ulcer, heartburn and stomach upset related to gastric acid, it can relieve the cardialgia, acid reflux, nausea, vomiting, abdominal distension and other symptoms caused by excessive gastric acid, and prevent the gastric mucosal lesions caused by nonsteroidal anti-inflammatory drugs.

In 2017, the market size of Hydrotalcite in China was close to CNY 110 million. The Hydrotalcite products in China are marketed in the dosage forms of suspension, tablets and granules. The market is dominated by the tablets.

By the end of 2018, more than 20 manufacturers have obtained the approval for Hydrotalcite production. However, China's Hydrotalcite market is highly concentrated. In 2017, by sales value, more than 90% market share went to the top 5 market players, namely, Bayer, Chongqing Pharscin Pharmaceutical Co., Ltd., Sichuan Jewelland Pharmaceutical Co., Ltd., Hainan Health Care Laboratories Ltd., and Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. And Bayer alone took up a market share of over 80%.

With the quickening pace of life, the change of dietary habits and the intensification of environmental pollution, the number of patients with gastrointestinal diseases in China will continue to rise in the coming years, which promises certain growth potential for China's Hydrotalcite market.

Buy Now@ https://www.kennethresearch.com/report-purchase-id-10060740

Topics Covered:
- Situation of gastrointestinal diseases in China
- Status of China's Hydrotalcite market
- Competition on China's Hydrotalcite market
- Prices of Hydrotalcite in China
- Major factors influencing the development of China's Hydrotalcite market
- Prospect of China's Hydrotalcite market, 2018-2022

Table of Contents

1 Relevant Concepts of Hydrotalcite
1.1 Indications for Hydrotalcite
1.2 Development of Hydrotalcite in China
1.3 Governmental Approval of Hydrotalcite in China

2 Sales of Hydrotalcite in China, 2013-2017
2.1 Sales Value of Hydrotalcite
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Hydrotalcite
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Hydrotalcite by Dosage Form in China, 2013-2017
2.3.1 Sales of Hydrotalcite Suspensions in China
2.3.2 Sales of Hydrotalcite Tablets in China
2.3.3 Sales of Hydrotalcite Granules in China

3 Analysis on Major Hydrotalcite Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Hydrotalcite Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Bayer
3.2.1 Profile of Bayer
3.2.2 Sales of Bayer's Hydrotalcite in China
3.3 Chongqing Pharscin Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Chongqing Pharscin Pharmaceutical Co., Ltd.'s Hydrotalcite in China
3.4 Sichuan Jewelland Pharmaceutical Co., Ltd.
3.5 Hainan Health Care Laboratories Ltd.
3.6 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.

Read More@ https://www.kennethresearch.com/report-details/investigation-report-on-chinas-hydrotalcite-market-2018-2022market/10060740

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

1412 Broadway,
21st Floor Suite MA111,
New York, NY 10018

Name:David
Email:sales@kennethresearch.com
Phone: +1 313 462 0609

This release was published on openPR.